Article abstract


Nature Cell Biology 11, 123 - 132 (2009)
Published online: 11 January 2009 | Corrected online: 13 January 2009 | doi:10.1038/ncb1821

Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation

Fuminori Tokunaga1,2,3, Shin-ichi Sakata1,2,3, Yasushi Saeki4, Yoshinori Satomi5, Takayoshi Kirisako3, Kiyoko Kamei1,3, Tomoko Nakagawa1,3, Michiko Kato3, Shigeo Murata4,6, Shoji Yamaoka7, Masahiro Yamamoto8, Shizuo Akira9, Toshifumi Takao5, Keiji Tanaka4 & Kazuhiro Iwai1,2,3


Nuclear factor-kappaB (NF-kappaB) is a key transcription factor in inflammatory, anti-apoptotic and immune processes. The ubiquitin pathway is crucial in regulating the NF-kappaB pathway. We have found that the LUBAC ligase complex, composed of the two RING finger proteins HOIL-1L and HOIP, conjugates a head-to-tail-linked linear polyubiquitin chain to substrates. Here, we demonstrate that LUBAC activates the canonical NF-kappaB pathway by binding to NEMO (NF-kappaB essential modulator, also called IKKgamma) and conjugates linear polyubiquitin chains onto specific Lys residues in the CC2–LZ domain of NEMO in a Ubc13-independent manner. Moreover, in HOIL-1 knockout mice and cells derived from these mice, NF-kappaB signalling induced by pro-inflammatory cytokines such as TNF-alpha and IL-1beta was suppressed, resulting in enhanced TNF-alpha–induced apoptosis in hepatocytes of HOIL-1 knockout mice. These results indicate that LUBAC is involved in the physiological regulation of the canonical NF-kappaB activation pathway through linear polyubiquitylation of NEMO.

Top
  1. Department of Biophysics and Biochemistry, Graduate School of Medicine and Cell Biology and Metabolism Group, Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan.
  2. CREST, Japan Science Technology Corporation, Kawaguchi, Saitama 332-0012, Japan.
  3. Department of Molecular Cell Biology, Graduate School of Medicine, Osaka City University, Abeno-ku, Osaka 545-8585
  4. Laboratory of Frontier Science, Core Technology and Research Center, Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo 113-8613, Japan.
  5. Laboratory of Protein Profiling and Functional Proteomics, Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan.
  6. Laboratory of Protein Metabolism, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  7. Department of Molecular Virology, Graduate School of Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8519, Japan.
  8. Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine
  9. Laboratory of Host Defense, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, 565-0871, Japan.

Correspondence to: Kazuhiro Iwai1,2,3 e-mail: kiwai@cellbio.med.osaka-u.ac.jp

* In the version of this article initially published online figure panels 3a, 3e and 7e were not clearly defined. Also (NEMOCC2~LZ) was corrected to (NEMO∆CC2~LZ). These errors have been corrected for the print, HTML and PDF versions of the article.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Linear polyubiquitylation: the missing link in NF?κB signalling

Nature Cell Biology News and Views (01 Feb 2009)

Smads keep TABs on inflammation

Nature Immunology News and Views (01 May 2007)

See all 3 matches for News And Views

Extra navigation

Subscribe to Nature Cell Biology

Subscribe